Denosumab: an investigational drug for the management of postmenopausal osteoporosis
E Michael LewieckiNew Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico, USAAbstract: Denosumab (AMG 162) is an investigational fully human monoclonal antibody with a high affinity and specificity for receptor activator of nuclear factor-κB ligand (RAN...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2008
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/8bc7daaabf8d46a99e2ef8cf5c1cd09a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|